These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23560129)

  • 1. Erosive nappy erythema following sunitinib intake.
    Kharmoum S; Errihani H
    Pan Afr Med J; 2013; 14():46. PubMed ID: 23560129
    [No Abstract]   [Full Text] [Related]  

  • 2. Sunitinib: a cause of bullous palmoplantar erythrodysesthesia, periungual erythema, and mucositis.
    Suwattee P; Chow S; Berg BC; Warshaw EM
    Arch Dermatol; 2008 Jan; 144(1):123-5. PubMed ID: 18209189
    [No Abstract]   [Full Text] [Related]  

  • 3. Scrotal cutaneous side effects of sunitinib.
    Billemont B; Barete S; Rixe O
    N Engl J Med; 2008 Aug; 359(9):975-6; discussion 976. PubMed ID: 18753659
    [No Abstract]   [Full Text] [Related]  

  • 4. Sunitinib-induced subungual splinter haemorrhage and acral erythema.
    Nakamura M; Miyachi Y
    Eur J Dermatol; 2008; 18(3):344-5. PubMed ID: 18474471
    [No Abstract]   [Full Text] [Related]  

  • 5. [Gottron-like papules induced by sunitinib].
    Martorell-Calatayud A; Sanmartín O; Traves-Zapata V; Guillén C
    Actas Dermosifiliogr; 2011 Jun; 102(5):385-7. PubMed ID: 21481331
    [No Abstract]   [Full Text] [Related]  

  • 6. Eruptive melanocytic nevi in a patient undergoing treatment with sunitinib.
    Jiménez-Gallo D; Albarrán-Planelles C; Linares-Barrios M; Martínez-Rodríguez A; Báez-Perea JM
    JAMA Dermatol; 2013 May; 149(5):624-6. PubMed ID: 23677103
    [No Abstract]   [Full Text] [Related]  

  • 7. Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib.
    Lipworth AD; Robert C; Zhu AX
    Oncology; 2009; 77(5):257-71. PubMed ID: 19923864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sunitinib-induced hand-foot syndrome: a new, distinct form.
    Fife DJ; Wu JJ; Behnam SE; Linden KG
    Clin Exp Dermatol; 2010 Mar; 35(2):200-1. PubMed ID: 19486049
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of pyoderma gangrenosum possibly associated with sunitinib treatment.
    Ueharaguchi Y; Kabashima K; Sasahashi M; Matsuda A; Matubara K; Matsui M
    Int J Dermatol; 2013 May; 52(5):634-6. PubMed ID: 23590380
    [No Abstract]   [Full Text] [Related]  

  • 10. Hand-foot syndrome and seborrheic dermatitis-like rash induced by sunitinib in a patient with advanced renal cell carcinoma.
    Tsai KY; Yang CH; Kuo TT; Hong HS; Chang JW
    J Clin Oncol; 2006 Dec; 24(36):5786-8. PubMed ID: 17179114
    [No Abstract]   [Full Text] [Related]  

  • 11. Palmar-plantar erythrodysesthesia secondary to sunitinib treatment resulting in necrotic foot syndrome aggravated by background diabetic vascular disease.
    Guenova E; Weber HO; Voykov B; Metzler G; Mitev V; Berneburg M; Hoetzenecker W; Röcken M
    Arch Dermatol; 2008 Aug; 144(8):1081-2. PubMed ID: 18711102
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cutaneous side effects of sorafenib and sunitinib].
    Autier J; Mateus C; Wechsler J; Spatz A; Robert C
    Ann Dermatol Venereol; 2008 Feb; 135(2):148-53; quiz 147, 154. PubMed ID: 18342102
    [No Abstract]   [Full Text] [Related]  

  • 13. Blackberry-induced hand-foot skin reaction to sunitinib.
    Boone SL; Jameson G; Von Hoff D; Lacouture ME
    Invest New Drugs; 2009 Aug; 27(4):389-90. PubMed ID: 18998055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
    Lee WJ; Lee JL; Chang SE; Lee MW; Kang YK; Choi JH; Moon KC; Koh JK
    Br J Dermatol; 2009 Nov; 161(5):1045-51. PubMed ID: 19558553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scrotal cutaneous toxicity: an uncommon but important side-effect of sunitinib.
    Gupta V; Rao A; Gupta S
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):132-3. PubMed ID: 25060046
    [No Abstract]   [Full Text] [Related]  

  • 16. Sunitinib-induced pseudoporphyria.
    Sanz-Motilva V; Martorell-Calatayud A; Llombart B; Requena C; Serra-Guillén C; Nagore E; Guillén C; Traves V; Sanmartín O
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1848-50. PubMed ID: 24813651
    [No Abstract]   [Full Text] [Related]  

  • 17. Sunitinib induced pyoderma gangrenosum-like ulcerations.
    Akanay-Diesel S; Hoff NP; Kürle S; Haes J; Erhardt A; Häussinger D; Schulte KW; Bölke E; Matuschek C; Budach W; Gerber PA; Homey B
    Eur J Med Res; 2011 Nov; 16(11):491-4. PubMed ID: 22027642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sunitinib-induced scrotal cutaneous side-effect.
    Chou CY; Wang KH; Lin YH; Lin YT; Tsai HH
    J Dermatol; 2013 Jan; 40(1):67-8. PubMed ID: 23078345
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiangiogenic agents and the skin: cutaneous adverse effects of sorafenib, sunitinib, and bevacizumab.
    Ara M; Pastushenko E
    Actas Dermosifiliogr; 2014 Dec; 105(10):900-12. PubMed ID: 24766821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Pseudocavitation" in thymic carcinoma during treatment with sunitinib.
    Tiseo M; Rajan A; Thomas A; Giaccone G
    J Thorac Oncol; 2013 Apr; 8(4):511-2. PubMed ID: 23486269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.